Polymer Capital Management (HK)’s Eli Lilly LLY Stock Holding History

Polymer Capital Management (HK)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40M	Sell	43,435 -2,375	-5%	-$2.41M	3.45%	5
2025 Q4	$49.2M	Sell	45,810 -2,105	-4%	-$2.01M	7%	2
2025 Q3	$36.6M	Buy	47,915 +29,221	+156%	+$21.7M	5.04%	2
2025 Q2	$14.6M	Buy	18,694 +13,166	+238%	+$10.2M	2.2%	12
2025 Q1	$4.57M	Buy	5,528 +570	+11%	+$474K	0.78%	40
2024 Q4	$3.83M	Buy	4,958 +4,458	+892%	+$3.69M	0.66%	44
2024 Q3	$443K	Buy	+500	New	+$450K	0.1%	117

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Polymer Capital Management (HK)'s LLY Position: Q1 2026 in Review

Polymer Capital Management (HK) reduced its Eli Lilly (LLY) stake by 5.2% in Q1 2026, selling an estimated $2.41M and leaving 43,435 shares worth $40M. The position accounts for 3.45% of the portfolio, ranked #5.

Polymer Capital Management (HK) first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $49.2M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Polymer Capital Management (HK) held 43,435 shares of Eli Lilly worth $40M as of Q1 2026.
Polymer Capital Management (HK) sold 2,375 Eli Lilly shares in Q1 2026, an estimated $2.41M.
Eli Lilly made up 3.45% of Polymer Capital Management (HK)'s portfolio in Q1 2026, its #5 holding.
Polymer Capital Management (HK) first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
Polymer Capital Management (HK)'s Eli Lilly position peaked at $49.2M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Polymer Capital Management (HK)'s 13F filing for Q1 2026, filed 14 May 2026.